Source:http://linkedlifedata.com/resource/pubmed/id/15483449
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2004-10-14
|
pubmed:abstractText |
This review outlines the limited information currently available on the effects of statins among patients with chronic kidney disease, and summarizes the ongoing randomized trials designed to address this question.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1062-4821
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
601-5
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15483449-Cardiovascular Diseases,
pubmed-meshheading:15483449-Clinical Trials as Topic,
pubmed-meshheading:15483449-Disease Progression,
pubmed-meshheading:15483449-Humans,
pubmed-meshheading:15483449-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:15483449-Kidney Failure, Chronic
|
pubmed:year |
2004
|
pubmed:articleTitle |
Statin therapy in kidney disease populations: potential benefits beyond lipid lowering and the need for clinical trials.
|
pubmed:affiliation |
Clinical Trial Service Unit and Epidemiological Studies Unit, Radcliffe Infirmary, Woodstock Road, Oxford, OX2 6HE, UK. colin.baigent@ctsu.ox.ac.uk
|
pubmed:publicationType |
Journal Article,
Review
|